PeptiDream (OTCMKTS:PPTDF – Get Free Report) is anticipated to post its results after the market closes on Wednesday, November 11th. Analysts expect the company to post earnings of ($0.0445) per share and revenue of $32.12 million for the quarter.
PeptiDream Stock Performance
PPTDF stock opened at $6.80 on Tuesday. PeptiDream has a 1-year low of $5.88 and a 1-year high of $12.85. The firm has a fifty day moving average price of $6.95 and a two-hundred day moving average price of $7.40.
About PeptiDream
PeptiDream Inc is a Japan-based biopharmaceutical company founded in 2006. It discovers and develops peptide-based drug candidates using its proprietary Peptide Discovery Platform System, known as PDPS.
The platform is designed to identify peptides, including macrocyclic peptides made with nonstandard amino acids, that can bind to drug targets. PeptiDream applies this technology to its own research programs and collaborates with pharmaceutical and biotechnology companies on drug discovery and development.
Based in Kawasaki, Japan, the company works with partners in Japan and internationally.
See Also
- Five stocks we like better than PeptiDream
- Wall Street May Be Making a Big Mistake With monday.com Stock
- Are These 2 Mid-Cap Growth Stocks Worth the Risk?
- Oklo Changes the Narrative: Does a Nuclear Stock Price Explosion Come Next?
- Cloudflare’s 20% Sell-Off May Have Created an Opening for Investors
Receive News & Ratings for PeptiDream Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PeptiDream and related companies with MarketBeat.com's FREE daily email newsletter.
